• Carbamazepine, Free, Serum
  • Estrogen/Progesterone Receptor, IHC
  • Anthrax DNA by Molecular Method
  • Tobramycin, Trough, Serum
  • Herpes Simplex Virus (HSV) 1 and 2 IgG
  • Amobarbital, Urine
  • Hydroxyzine, Urine
  • Clonazepam, Urine
  • Platelet Function Analysis
  • Vaginosis/Vaginitis Pathogen Detection Panel by Molecular Method
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Additional Testing
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.